138
Participants
Start Date
December 31, 2005
Primary Completion Date
March 31, 2010
Study Completion Date
March 31, 2012
Cyclophosphamide (drug)
IV cyclophosphamide infusion administered every 4 weeks during 1 year and every 8 weeks during 1 year.
Methylprednisolone (drug)
Control group : IV methylprednisolone infusion administered every 4 weeks during 1 year and every 8 weeks during 1 year.
Hôpital La Timone, Marseille
CHU Caen, Caen
CH d'Angoulême Girac, Saint-Michel
CHU Dijon, Dijon
CHU Besançon, Besançon
(CHU Nîmes) Hôpital Caremeau, Nîmes
Hôpital Pellegrin, Département de neurologie, Bordeaux
(CHU Montpellier), Hôpital de Gui de Chauliac, Montpellier
CHU Ponchaillou, Rennes
Hôpital Guillaume et René Laënnec, Nantes
(CHU Reims) Hôpital Robert Debré, Reims
CHU Nancy Hôpital central, Nancy
(CHR Metz-Thionville) Hôpital Notre Dame de Bon Secours, Metz
CHU Lille Hôpital Salengro, Lille
GHICL Hôpital St. Philibert, Lomme
Hôpital Gabriel Montpied, Clermont-Ferrand
Centre Hospitalier de Pau, Pau
CH de la Cote Basque, Bayonne
(CHRU Starsbourg) Hôpital civil, Strasbourg
(CHU Lyon) Hôpital neurologique, Lyon
Fondation Rothschild, Paris
(AP HP) Hôpital Tenon, Paris
CHU de POISSY, Poissy
CHU Limoges, Limoges
AP HP Henri Mondor, Créteil
CHU Nice Hôpital Pasteur, Nice
Ministry of Health, France
OTHER_GOV
University Hospital, Bordeaux
OTHER